 Connection
Jason Burdick to Delayed-Action Preparations
This is a "connection" page, showing publications Jason Burdick has written about Delayed-Action Preparations.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.472 |
|
|
|
-
Wang LL, Chung JJ, Li EC, Uman S, Atluri P, Burdick JA. Injectable and protease-degradable hydrogel for siRNA sequestration and triggered delivery to the heart. J Control Release. 2018 09 10; 285:152-161.
Score: 0.522
-
Rosales AM, Rodell CB, Chen MH, Morrow MG, Anseth KS, Burdick JA. Reversible Control of Network Properties in Azobenzene-Containing Hyaluronic Acid-Based Hydrogels. Bioconjug Chem. 2018 04 18; 29(4):905-913.
Score: 0.509
-
Highley CB, Kim M, Lee D, Burdick JA. Near-infrared light triggered release of molecules from supramolecular hydrogel-nanorod composites. Nanomedicine (Lond). 2016 06; 11(12):1579-90.
Score: 0.450
-
Ramanan VV, Hribar KC, Katz JS, Burdick JA. Nanofiber-nanorod composites exhibiting light-induced reversible lower critical solution temperature transitions. Nanotechnology. 2011 Dec 09; 22(49):494009.
Score: 0.330
-
Chen MH, Chung JJ, Mealy JE, Zaman S, Li EC, Arisi MF, Atluri P, Burdick JA. Injectable Supramolecular Hydrogel/Microgel Composites for Therapeutic Delivery. Macromol Biosci. 2019 01; 19(1):e1800248.
Score: 0.133
-
Vega SL, Kwon MY, Burdick JA. Recent advances in hydrogels for cartilage tissue engineering. Eur Cell Mater. 2017 01 30; 33:59-75.
Score: 0.118
-
Rodell CB, Rai R, Faubel S, Burdick JA, Soranno DE. Local immunotherapy via delivery of interleukin-10 and transforming growth factor ß antagonist for treatment of chronic kidney disease. J Control Release. 2015 May 28; 206:131-9.
Score: 0.104
-
Holloway JL, Ma H, Rai R, Burdick JA. Modulating hydrogel crosslink density and degradation to control bone morphogenetic protein delivery and in vivo bone formation. J Control Release. 2014 Oct 10; 191:63-70.
Score: 0.098
-
Marklein RA, Burdick JA. Controlling stem cell fate with material design. Adv Mater. 2010 Jan 12; 22(2):175-89.
Score: 0.073
-
Burdick JA, Ward M, Liang E, Young MJ, Langer R. Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. Biomaterials. 2006 Jan; 27(3):452-9.
Score: 0.054
-
Purcell BP, Barlow SC, Perreault PE, Freeburg L, Doviak H, Jacobs J, Hoenes A, Zellars KN, Khakoo AY, Lee T, Burdick JA, Spinale FG. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling. Am J Physiol Heart Circ Physiol. 2018 10 01; 315(4):H814-H825.
Score: 0.033
-
Cohen JE, Purcell BP, MacArthur JW, Mu A, Shudo Y, Patel JB, Brusalis CM, Trubelja A, Fairman AS, Edwards BB, Davis MS, Hung G, Hiesinger W, Atluri P, Margulies KB, Burdick JA, Woo YJ. A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy. Circ Heart Fail. 2014 Jul; 7(4):619-26.
Score: 0.025
-
MacArthur JW, Purcell BP, Shudo Y, Cohen JE, Fairman A, Trubelja A, Patel J, Hsiao P, Yang E, Lloyd K, Hiesinger W, Atluri P, Burdick JA, Woo YJ. Sustained release of engineered stromal cell-derived factor 1-a from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction. Circulation. 2013 Sep 10; 128(11 Suppl 1):S79-86.
Score: 0.023
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|